Biomira, Cambridge Biotech Corp. deal

BIOMF (Edmonton) purchased CBCX's 54 percent interest in ADI Diagnostics for $1.5 million. ADI, which develops, manufactures and distributes diagnostic and screening kits to detect infectious and sexually transmitted diseases, has manufactured and distributed BIOMF's Truquant cancer diagnostic kits since 1992.

ADI recorded a net loss of $2.4 million on revenues of $2.9 million in 1993. ...